Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19301,331,1.39 [1.24-1.55],1.131165166766276e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,17214,308,2.82 [1.88-4.24],5.120033171797598e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,19402,328,1.52 [1.29-1.79],3.940651219674426e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,19556,336,2.17 [1.54-3.06],8.605383283370498e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,19667,335,2.00 [1.62-2.46],5.94705794610907e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,16677,295,2.35 [1.79-3.07],5.0283103508214e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,19402,328,1.96 [1.42-2.71],4.567372679596623e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,19592,336,0.49 [0.37-0.64],2.4102126373189295e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17141,308,2.26 [1.63-3.12],8.818045561701964e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,17201,308,3.31 [2.55-4.29],2.615829502385287e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,16814,295,2.30 [1.80-2.93],1.6483492533067373e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,19668,335,1.37 [1.24-1.52],2.163835149692111e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,17206,307,1.49 [1.27-1.75],1.4431905698563929e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,19939,343,3.84 [2.65-5.55],9.090145844150761e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,19840,341,1.66 [1.30-2.12],5.593062897389167e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",19641,335,1.21 [1.11-1.33],3.197835839933669e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",19716,332,1.28 [1.13-1.45],7.244473770534162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",19668,335,1.25 [1.16-1.35],5.360718622324482e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,19939,343,3.02 [2.41-3.77],5.0698333776352e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,19459,324,2.56 [1.82-3.61],7.805310115670452e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,19811,340,1.99 [1.60-2.46],2.9208020371272144e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,19332,331,1.38 [1.24-1.54],4.334232476050843e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,19867,338,2.83 [2.04-3.93],5.497366473145606e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,19764,335,0.60 [0.49-0.73],6.682394829069546e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,19668,335,2.75 [2.27-3.33],6.326671754291632e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,19592,336,2.43 [1.81-3.25],2.9070502919065244e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,17206,307,1.71 [1.34-2.17],1.1912836723094514e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",19840,341,2.15 [1.53-3.01],9.447659990024412e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,19776,339,2.34 [1.61-3.39],6.979856836187165e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,19592,336,0.29 [0.22-0.39],1.0521161502266717e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,16814,295,2.86 [1.88-4.36],1.0370502255341188e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,19738,336,1.57 [1.34-1.83],1.3522939078042569e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,19972,341,3.99 [2.58-6.17],5.018376937347292e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,19950,342,1.65 [1.43-1.90],9.672583193517927e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,19867,338,1.84 [1.49-2.26],1.0971985712595052e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,16796,302,4.36 [3.24-5.87],2.7110245276473724e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,19668,335,1.77 [1.36-2.32],2.666672671315016e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,19939,343,0.46 [0.35-0.60],1.4771341135959252e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,20015,341,2.62 [1.78-3.87],1.2492005926668977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,19716,339,0.69 [0.59-0.81],2.8709975283362844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,19939,343,1.66 [1.39-1.98],3.3758658652852955e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,19565,336,1.31 [1.15-1.49],3.213812040296939e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,19764,335,2.18 [1.71-2.79],5.079001426682359e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,20006,342,1.44 [1.32-1.57],1.4031093717485746e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,19840,341,2.33 [1.93-2.81],8.78938734269767e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,19542,333,1.75 [1.48-2.08],7.231458744759593e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,19689,330,1.42 [1.22-1.66],6.4874521661004095e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,19752,333,1.41 [1.22-1.64],5.279362264856313e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,19979,339,1.79 [1.38-2.31],1.0644361347706907e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,19405,329,2.11 [1.68-2.64],7.015741651058716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,19867,338,1.90 [1.54-2.34],1.907499232181312e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,19829,337,1.98 [1.61-2.42],5.863090552784585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,19592,336,1.94 [1.50-2.50],3.165027088188447e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,19740,338,2.13 [1.61-2.81],9.056396869037013e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,19950,342,1.92 [1.48-2.50],9.586285823132215e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,19885,343,2.01 [1.62-2.48],1.1747175953656924e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,19939,343,1.61 [1.35-1.91],9.634325123627272e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,19668,335,2.27 [1.72-2.99],5.9654534504702304e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,19811,340,2.15 [1.59-2.92],6.900117757031157e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,17124,305,1.81 [1.44-2.28],3.570250835188729e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,19752,333,1.61 [1.29-2.02],2.614419606063952e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,19950,342,2.06 [1.59-2.66],3.674462865293992e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,17199,308,2.52 [1.89-3.35],2.0206768796534844e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,19752,333,2.28 [1.78-2.93],9.138479154409094e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,19592,336,1.75 [1.50-2.04],8.216027033582807e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,19764,335,1.77 [1.36-2.31],2.383692745302357e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,19764,335,0.59 [0.47-0.76],2.3734924762518413e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,19800,336,5.92 [3.91-8.95],3.896752578265187e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,17141,308,0.50 [0.43-0.57],1.2694351664270081e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19054,325,1.62 [1.42-1.85],9.03699142967994e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17201,308,1.87 [1.55-2.25],9.169142309133326e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19402,328,1.48 [1.23-1.77],2.34192760805014e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,16916,301,2.18 [1.53-3.09],1.3886941852393491e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,16233,291,2.75 [1.67-4.54],6.973897506555753e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,19776,339,1.51 [1.30-1.75],6.781173643646158e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,19764,335,1.58 [1.27-1.97],4.990481530099008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17155,308,1.80 [1.44-2.24],2.3401161839449737e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,17140,308,2.24 [1.64-3.06],4.024401733227594e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,17201,308,1.41 [1.27-1.56],2.4564513070831584e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,19353,329,1.55 [1.41-1.72],7.073156263456117e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,19811,340,2.46 [1.85-3.27],6.738722022018731e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,17201,308,1.61 [1.30-1.99],1.2176701341697422e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,19903,340,2.13 [1.59-2.85],3.4472634240311294e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,17201,308,1.88 [1.56-2.26],1.858703007009921e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,19776,339,2.00 [1.48-2.69],4.924553105813934e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,16829,300,0.20 [0.11-0.35],1.3272055503042492e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,19752,333,1.51 [1.30-1.75],4.318457953035109e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,19695,334,2.53 [1.89-3.39],3.6170182577511054e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,19301,331,1.95 [1.61-2.37],1.2225636810980097e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,16735,300,1.69 [1.37-2.08],7.720831288138768e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,20006,342,1.84 [1.50-2.26],6.276900075644975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,17155,308,2.29 [1.63-3.20],1.4300896011376168e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,19867,338,0.53 [0.45-0.64],4.708220199238812e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,19854,340,3.51 [2.37-5.19],3.145705866109238e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,19764,335,2.20 [1.76-2.74],3.00817387579201e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,16814,295,2.09 [1.65-2.63],5.356151744259755e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,20015,341,2.26 [1.79-2.85],7.182622413703508e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,19752,333,1.86 [1.53-2.27],7.974860500734963e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,19740,338,2.78 [2.01-3.84],6.580594515399219e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,19518,329,1.90 [1.53-2.36],7.0009879302294995e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,16814,295,1.84 [1.37-2.49],5.84343079771137e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,19266,331,0.78 [0.69-0.88],5.933516798667751e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,19840,341,3.88 [2.48-6.06],2.60884932172443e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,19939,343,0.67 [0.56-0.79],1.548541393765727e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,19840,341,3.06 [2.22-4.21],6.795275155240256e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,17214,308,1.83 [1.44-2.32],9.271757623343689e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,19771,340,1.22 [1.12-1.32],6.097996193376216e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,19510,336,1.59 [1.28-1.96],2.420966044637777e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,17201,308,2.31 [1.58-3.38],1.4604624272935593e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,18486,309,1.77 [1.46-2.16],1.3096212341724949e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,19764,335,2.53 [1.73-3.71],1.874233220325844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,19752,333,1.95 [1.65-2.31],1.0478876885147796e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,19950,342,1.35 [1.21-1.51],7.853470004835431e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,19950,342,1.37 [1.21-1.54],4.054686812044251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,19982,340,3.05 [2.05-4.53],3.284692905364692e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,20006,342,2.13 [1.80-2.52],1.776701100960609e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,19840,341,1.38 [1.21-1.57],1.8962051248554748e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",19829,337,2.14 [1.64-2.80],1.8638019379886442e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",19668,335,1.66 [1.36-2.03],7.167333209467507e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,19950,342,2.54 [1.79-3.59],1.6627477972450144e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,19829,337,2.27 [1.69-3.06],6.891599004727616e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,19752,333,1.57 [1.25-1.96],8.735369844768414e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,19614,332,1.56 [1.33-1.81],1.5658500254773972e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,17102,307,1.56 [1.25-1.94],9.86424243704474e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,19916,343,1.83 [1.35-2.46],7.863701657101832e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,19939,343,1.90 [1.52-2.37],1.3204557725661586e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,19752,333,0.76 [0.68-0.85],1.7882464843665308e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,17140,308,0.65 [0.52-0.80],5.525250284889527e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19402,328,2.07 [1.63-2.64],3.991289060246943e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,16725,292,2.46 [1.73-3.50],6.178087094168471e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,19835,337,2.68 [2.03-3.54],4.039439557555554e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,19744,339,1.92 [1.42-2.61],2.86711074393394e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,19556,336,1.76 [1.35-2.31],3.5217843642304106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,19301,331,1.70 [1.33-2.17],2.3377683293919703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,20015,341,0.15 [0.08-0.28],9.217555451842795e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,17199,308,1.93 [1.44-2.60],1.3114929201966444e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,19171,328,1.37 [1.22-1.54],1.458368644765959e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,19051,329,2.23 [1.70-2.92],6.548277876048289e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,20015,341,2.16 [1.53-3.06],1.4727770809567368e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,19909,343,1.79 [1.34-2.38],6.713540528134637e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,19829,337,2.16 [1.48-3.17],7.686728520066829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",19740,338,1.35 [1.23-1.48],2.3782655910512967e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",20015,341,1.59 [1.34-1.89],1.1906565500560161e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,17199,308,2.34 [1.60-3.42],1.2062268081525826e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,17201,308,2.14 [1.54-2.97],4.903498196393177e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",19764,335,1.31 [1.16-1.49],1.6427334542046375e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,19752,333,1.81 [1.48-2.21],7.265389482688665e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,17185,308,1.76 [1.40-2.21],1.0043934303829967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,19301,331,1.41 [1.24-1.60],1.585970020708313e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,16821,300,2.28 [1.61-3.23],3.565623010797249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,19916,343,1.40 [1.30-1.49],1.6887500147013738e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,19904,343,1.38 [1.19-1.60],1.8234232112470488e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,19829,337,2.98 [2.02-4.40],3.7111863734233584e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,17214,308,2.13 [1.83-2.49],5.81780894798622e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,19592,336,2.00 [1.42-2.82],6.804615590383882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,19631,335,2.40 [1.61-3.59],1.9847020853759195e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,19757,335,1.87 [1.38-2.53],5.056856849388202e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,19950,342,2.17 [1.57-2.99],2.557228971948116e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,16725,292,5.61 [3.58-8.81],6.253269632393237e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,19713,338,3.08 [2.39-3.96],3.5208749909549056e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,19950,342,2.03 [1.66-2.49],1.1024212013785309e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,19668,335,2.37 [1.70-3.33],4.828690557710984e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,17199,308,2.77 [1.94-3.96],2.260481758558608e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,19892,340,3.00 [2.06-4.36],9.005274075466462e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,17155,308,1.31 [1.21-1.40],5.485730594682946e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16390,289,1.53 [1.27-1.85],8.493159461595082e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,20015,341,2.29 [1.97-2.66],1.0243662283165068e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,19916,343,2.59 [1.91-3.52],1.0178473359351004e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,19744,339,1.82 [1.56-2.12],1.4207787766660836e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,19592,336,3.42 [2.36-4.95],7.285877441295446e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,16814,295,0.41 [0.28-0.61],1.2630392236233023e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,17155,308,2.04 [1.50-2.77],5.554945753630061e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,19402,328,1.53 [1.29-1.82],1.8213226942730485e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,16786,300,1.72 [1.39-2.15],1.0849470558068358e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,19950,342,2.25 [1.55-3.26],1.922795206094807e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,19592,336,0.64 [0.53-0.76],9.613159278770222e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,17140,308,1.45 [1.22-1.71],1.4862726975220268e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",19668,335,1.68 [1.47-1.92],4.857389376347047e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,19854,339,1.49 [1.28-1.75],6.381400771388105e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,19911,341,1.73 [1.52-1.96],1.3812452237729085e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,19776,339,2.07 [1.62-2.66],8.977719357021849e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,16814,295,2.78 [1.88-4.11],3.21106411874982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,20006,342,2.71 [2.16-3.39],4.363208392660563e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",19752,333,1.90 [1.40-2.59],4.724703454353002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,19301,331,0.48 [0.36-0.63],1.429494368207256e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,19752,333,1.67 [1.31-2.13],2.8330223384961124e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,19635,332,2.24 [1.64-3.06],3.313758831246536e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,19686,335,3.26 [2.20-4.82],3.5432400624598582e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,19695,335,3.71 [2.80-4.92],6.973375208370703e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,20015,341,1.99 [1.42-2.79],6.873485085599311e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,19764,335,2.35 [1.90-2.92],7.963308762946278e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,19939,343,1.56 [1.26-1.93],5.137166961789377e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,16730,300,2.38 [1.88-3.02],6.853738399248126e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,19776,339,2.44 [1.64-3.61],9.254686967832378e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,19985,341,1.34 [1.24-1.45],3.9973558196711384e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,19988,341,1.72 [1.47-2.02],2.562781723543621e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,19867,338,0.36 [0.28-0.46],1.129641878893265e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,19530,336,1.78 [1.48-2.14],9.580763764224712e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,20015,341,2.60 [2.07-3.28],4.651100386537242e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,19764,335,2.82 [2.20-3.62],3.225208005780733e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,17187,306,2.40 [1.84-3.13],1.3664722217511628e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,19668,335,1.78 [1.45-2.18],3.736565585404138e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,17199,308,1.29 [1.14-1.45],4.263966867913008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,19840,341,2.55 [1.94-3.37],3.5007115479422806e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,19752,333,2.43 [1.84-3.21],4.030377840081965e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,19413,332,1.34 [1.18-1.53],6.97214737934045e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,19673,336,1.79 [1.45-2.20],5.164367819215883e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,19867,338,2.53 [1.92-3.34],5.5347224385924955e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,19269,329,1.50 [1.34-1.69],4.661941856607088e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,19776,339,0.56 [0.44-0.72],3.01191034740018e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,19945,340,2.14 [1.75-2.63],3.04683179102516e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,19413,332,0.36 [0.28-0.47],7.0727516663846e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,19699,339,1.56 [1.34-1.81],6.022191762477085e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,17140,308,1.57 [1.36-1.80],4.594631513781533e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,19630,336,2.31 [1.86-2.86],2.2993143111051102e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,19752,333,1.57 [1.29-1.91],6.136946333188246e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,19752,333,2.11 [1.69-2.64],6.395355298920328e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,19668,335,1.56 [1.42-1.72],8.558274129024152e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,19764,335,3.38 [1.97-5.81],1.0633285581338787e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,17140,308,1.56 [1.25-1.94],8.426428210324442e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,16814,295,1.72 [1.41-2.09],6.114858284305331e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,17155,308,0.66 [0.58-0.74],2.4267464640972124e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,16677,295,3.72 [2.01-6.90],2.9842419283082344e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,19776,339,3.17 [2.19-4.59],1.0368924154687995e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,19939,343,0.30 [0.17-0.52],1.6607897587666657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,17201,308,2.15 [1.71-2.72],8.926065791407451e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,19867,338,2.53 [1.95-3.29],3.505078929119548e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,19413,332,1.42 [1.21-1.68],2.2148851084012566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,19837,338,0.49 [0.35-0.68],2.152234197077663e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,19764,335,0.48 [0.38-0.61],1.449622522882301e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,19780,335,1.79 [1.45-2.22],7.487859366536403e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,19641,335,1.79 [1.40-2.29],3.951453536532958e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,17201,308,0.79 [0.71-0.88],3.1487988134162465e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,19939,343,1.43 [1.24-1.63],3.375281518559992e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,19740,338,1.73 [1.41-2.13],1.6081549374839224e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,16725,301,1.73 [1.34-2.22],1.982892795157352e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,19972,341,1.84 [1.56-2.18],8.956532314067217e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,19565,336,1.89 [1.47-2.43],5.478811665587248e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,19867,338,1.45 [1.23-1.71],1.1184345136916158e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,17214,308,0.35 [0.22-0.57],2.4514609274108263e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,16262,282,1.36 [1.16-1.59],9.979950892786574e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,19764,335,2.05 [1.54-2.71],6.006700424287515e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,17206,307,2.55 [1.90-3.42],3.6457886929799454e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,19740,338,1.94 [1.66-2.27],1.10920748275262e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,19742,339,2.36 [1.78-3.12],1.771316315743986e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,19840,341,2.30 [1.78-2.97],2.3744913455318636e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,19752,333,2.91 [2.03-4.18],7.250222896012421e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,19776,339,1.79 [1.35-2.39],6.848900433960803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,19737,335,2.36 [1.75-3.17],1.3931313721367637e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,17206,307,3.23 [2.19-4.75],2.798817370092727e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,19668,335,1.85 [1.49-2.31],2.903126467345893e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,19413,332,0.45 [0.35-0.58],1.3581124435247426e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,20015,341,2.54 [1.96-3.29],1.768768626483433e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,19301,331,1.49 [1.27-1.74],6.512098928964297e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,19634,336,2.25 [1.66-3.05],1.717801398686459e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,19539,332,1.89 [1.39-2.57],5.352939839752168e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,19592,336,2.53 [2.01-3.18],2.2001492153687438e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,17206,307,3.74 [2.12-6.62],5.785916912239063e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,16595,297,0.45 [0.31-0.66],3.913292466923591e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,19768,339,3.04 [2.22-4.16],4.2933202756498734e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,19769,335,1.70 [1.45-2.00],8.550862928960055e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,19764,335,0.75 [0.69-0.82],5.477943377781525e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,19752,333,1.20 [1.09-1.31],9.294746876687975e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,19413,332,1.47 [1.22-1.76],3.844103857459701e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,19700,337,1.39 [1.18-1.63],8.620619015179925e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,19805,340,2.05 [1.75-2.40],6.575690723799042e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,19374,327,2.15 [1.73-2.66],3.502007639419341e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,19917,341,1.50 [1.33-1.70],7.651542868933229e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,19748,339,1.64 [1.40-1.93],1.8840405907962072e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,17214,308,4.79 [3.37-6.80],2.0798598079442494e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,19633,335,1.60 [1.39-1.83],4.188532676994738e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,19950,342,2.13 [1.75-2.59],3.8668935347852864e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,19402,328,0.58 [0.48-0.69],2.15453762124537e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,19413,332,1.37 [1.23-1.53],2.4224859938061386e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,19797,340,2.02 [1.70-2.40],1.0630808657066797e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,19950,342,0.57 [0.44-0.74],1.3979202387640207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,19737,335,2.13 [1.60-2.83],2.444461839438495e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,19829,337,1.68 [1.30-2.18],8.735731707284259e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,19277,329,1.58 [1.31-1.92],2.961505392156977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,20006,342,2.08 [1.52-2.83],3.874163204553916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19413,332,1.52 [1.32-1.76],9.489439244271609e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,16419,291,2.74 [1.91-3.94],4.719833083743723e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,19768,339,2.54 [1.83-3.53],2.8365528324155825e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",19332,331,1.44 [1.23-1.69],4.329944485428329e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,16910,302,2.41 [1.86-3.11],1.558122005601016e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,19764,335,1.70 [1.32-2.19],4.400689056327498e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,19776,339,1.62 [1.30-2.00],1.0673626641292144e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,19900,338,2.58 [1.82-3.67],1.2100374481755725e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,17155,308,2.19 [1.69-2.85],3.4334052524887393e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,19764,335,1.27 [1.17-1.38],3.366177274494053e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,17167,307,2.37 [1.95-2.89],9.10708278202218e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,19565,332,1.38 [1.20-1.59],5.348867141770778e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,19668,335,0.71 [0.61-0.82],2.6582755755569627e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,17145,307,2.82 [1.68-4.76],9.75278841441618e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,19768,339,2.80 [2.09-3.74],3.1898361486779047e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,19652,331,1.54 [1.34-1.76],4.6035144423234924e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,19900,338,6.25 [3.91-10.01],2.1637529532878075e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,17155,308,2.23 [1.76-2.82],1.900324309996861e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,20015,341,1.67 [1.31-2.13],3.543496611660687e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,16677,295,1.56 [1.26-1.92],3.571131316797085e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,17214,308,1.40 [1.20-1.62],1.37121690775158e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,20006,342,2.18 [1.58-3.01],2.151989404465113e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,19516,337,1.57 [1.34-1.83],1.3562195777901564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,19515,335,4.03 [3.22-5.03],1.4444769626587914e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,19776,339,2.15 [1.71-2.72],8.753393189281129e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,19764,335,1.59 [1.33-1.92],6.866448239580579e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,17199,308,2.67 [1.78-4.02],2.160966307926063e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,19829,337,4.84 [3.53-6.64],1.7236733303786726e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,19987,341,0.61 [0.50-0.76],4.654890859859306e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",19744,337,1.43 [1.23-1.65],1.3395359364239895e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,19776,339,0.45 [0.33-0.60],6.902079692256247e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,19945,340,1.66 [1.38-2.00],1.0924168519068157e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,19776,339,2.48 [1.91-3.23],1.2897430447525354e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,19605,336,5.50 [4.17-7.26],2.044506624689985e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,19913,340,2.40 [1.66-3.48],3.7921670269599487e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,17201,308,1.99 [1.48-2.69],6.0506797587078985e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,16677,295,2.19 [1.74-2.76],3.919618477725466e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,19670,339,2.80 [2.27-3.45],5.084145145421796e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,19939,343,2.63 [1.87-3.71],3.2064899065084834e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,17043,304,2.76 [2.02-3.76],1.5526812914807176e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,19332,331,1.86 [1.42-2.44],7.79558890791336e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,19402,328,1.77 [1.48-2.13],9.956655489890434e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,17141,308,2.32 [1.53-3.53],7.814193917739037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,19950,342,2.31 [1.85-2.89],1.2041998795319733e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17167,307,1.79 [1.44-2.21],9.161890711504173e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,19668,335,1.33 [1.18-1.50],5.063350143095426e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,19764,335,1.48 [1.33-1.65],3.847903391065256e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,17214,308,2.59 [1.81-3.71],2.1036027981646802e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,16664,295,2.41 [1.71-3.40],5.214693102936637e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,17101,307,2.03 [1.62-2.53],5.837690598391185e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,19929,340,2.76 [1.97-3.84],2.455713724112046e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,16725,292,2.42 [1.76-3.34],6.711295672388788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,19768,339,2.29 [1.56-3.34],2.0715476621583344e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,19592,336,1.85 [1.41-2.42],6.8076246622041465e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,19950,342,2.44 [1.76-3.39],9.652761101413341e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,19772,339,0.62 [0.53-0.73],2.515799861876877e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,19811,340,1.25 [1.13-1.39],2.0830197043885205e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,16735,300,0.58 [0.45-0.74],2.2781706978886096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,17206,307,0.28 [0.17-0.46],4.260913030671123e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,17167,307,1.32 [1.15-1.51],7.580205368591032e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,17124,306,2.13 [1.61-2.82],1.3455062138441338e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,20015,341,1.96 [1.54-2.49],5.053456875263196e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,17158,306,4.48 [2.56-7.82],1.4024669277372414e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,16912,303,0.37 [0.23-0.59],3.000768065140031e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,17178,306,3.36 [1.84-6.12],7.523102600082829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,19668,335,2.18 [1.54-3.08],1.2070826421032549e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,19522,335,1.55 [1.27-1.88],1.089459376391714e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,19301,331,1.38 [1.19-1.59],2.19873469426657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,19301,331,1.42 [1.21-1.66],1.3566687201000096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,17214,308,1.85 [1.44-2.37],1.480782338779518e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,17201,308,2.58 [1.92-3.48],4.54456538740861e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,19793,337,1.62 [1.32-1.99],5.044131965918879e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,19840,341,2.14 [1.73-2.65],2.0349124347122968e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,19752,333,1.92 [1.49-2.47],5.134286809256103e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,19413,332,1.45 [1.22-1.72],1.929278352280436e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,19752,333,1.64 [1.41-1.91],1.9150585743305343e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,19301,331,1.62 [1.33-1.96],1.100431634232891e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,19332,331,1.38 [1.19-1.61],2.457287972164322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,19840,341,1.80 [1.42-2.29],1.5364802336395529e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,19859,340,1.73 [1.45-2.05],6.477285838325531e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",19776,339,2.07 [1.67-2.58],6.559066878129148e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,19776,339,1.72 [1.41-2.10],9.350159540197465e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,19703,338,3.00 [2.25-4.00],6.180637796613354e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,19768,339,2.66 [2.04-3.46],3.108694064358828e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,19670,335,2.46 [1.90-3.19],1.0538981739529104e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,19988,341,1.58 [1.29-1.95],1.1529414925884662e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,19737,335,0.67 [0.62-0.74],2.618651798506961e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20015,341,2.30 [1.74-3.04],4.199211088667666e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,19752,333,1.48 [1.30-1.69],2.0198178306464543e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,19776,339,2.43 [1.85-3.20],2.503110852519341e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,16883,303,1.89 [1.47-2.42],4.689076830620955e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,19988,341,2.10 [1.59-2.78],1.9650447287397938e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,17199,308,2.28 [1.60-3.25],5.746349736745066e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,19683,336,1.46 [1.31-1.62],3.1916978369628688e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,19811,340,2.10 [1.83-2.42],2.2903691669104878e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,19774,335,1.89 [1.56-2.29],1.3198609213298742e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,19776,335,1.58 [1.34-1.86],4.94924068059957e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,19752,333,1.99 [1.67-2.38],2.9751261958324263e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,19972,341,1.90 [1.51-2.40],5.917455320537621e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,19829,337,1.85 [1.44-2.37],1.637695186621359e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,19776,339,2.57 [2.11-3.13],8.721354001314821e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,19802,337,1.53 [1.24-1.88],6.810659724342037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,19580,332,2.81 [2.14-3.69],1.3030812963232657e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,19776,339,2.41 [1.95-2.99],9.45214320034971e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,17124,306,1.87 [1.44-2.45],3.8703253523126615e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,19867,338,1.78 [1.46-2.15],6.10514539762079e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,19592,336,2.61 [2.06-3.31],1.5994058117915485e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,19592,336,1.61 [1.41-1.83],1.300009953103379e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20006,342,1.60 [1.27-2.00],5.483825922782254e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,19740,338,3.39 [2.54-4.53],1.6390434664745178e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,19829,337,2.07 [1.64-2.63],1.7703024177480122e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,19768,339,1.97 [1.48-2.62],3.386371766213919e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,19776,339,2.48 [1.88-3.25],7.447663846298866e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,19776,339,1.85 [1.54-2.23],4.779856405958408e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,19972,341,1.66 [1.30-2.10],3.6315951811799455e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,19592,336,1.56 [1.34-1.82],6.071606211987133e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,19752,333,0.72 [0.62-0.85],8.029678570218921e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,20006,342,0.47 [0.33-0.67],2.626280725665889e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,19840,341,2.37 [1.68-3.33],7.281125693595345e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,19982,340,2.54 [1.92-3.38],1.0452050239208e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,19592,336,0.55 [0.43-0.70],5.973745643674218e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,19608,336,1.89 [1.60-2.24],1.974464865121145e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,19740,338,1.81 [1.53-2.14],4.421378895568193e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,17141,308,1.35 [1.20-1.51],3.215518763432552e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,17033,304,0.29 [0.20-0.43],1.1067881305604051e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,19829,337,2.55 [1.84-3.54],1.93944570160858e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,19592,336,1.77 [1.40-2.24],1.5189211858950875e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,19402,328,1.47 [1.27-1.71],2.222909523754701e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,19837,338,2.02 [1.46-2.81],2.721624023567891e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,19942,342,1.44 [1.23-1.68],7.240875639342036e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,16677,295,2.94 [2.00-4.32],3.687983121177333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,19668,335,2.09 [1.66-2.64],5.605128472163312e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17140,308,1.84 [1.58-2.13],9.098720048103286e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,19754,339,1.94 [1.57-2.41],1.4378275055453975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,19301,331,1.82 [1.35-2.46],9.953691375760668e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,19916,343,2.09 [1.69-2.58],1.2424660402322847e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,18815,314,2.27 [1.88-2.74],1.2012158397842076e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",19518,334,0.30 [0.24-0.39],1.5259217914943365e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,17155,308,2.23 [1.61-3.09],1.4123850651531588e-06
